Introduction: The following is a summary of the official guidelines of the Italian Association for the Study of the Pancreas regarding the medical, endoscopic and surgical management of acute pancreatitis. Statements: Clinical features together with elevation of the plasma concentrations of pancreatic enzymes are the cornerstones of diagnosis (recommendation A). Contrast-enhanced computed tomography (CT) provides good evidence for the presence of pancreatitis (recommendation C) and it should be carried out 48–72 h after the onset of symptoms in patients with predicted severe pancreatitis. Severity assessment is essential for the selection of the proper initial treatment in the management of acute pancreatitis (recommendation A) and should be done using the APACHE II score, serum C-reactive protein and CT assessment (recommendation C). The etiology of acute pancreatitis should be able to be determined in at least 80% of cases (recommendation B). An adequate volume of intravenous fluid should be administered promptly to correct the volume deficit and maintain basal fluid requirements (recommendation A); analgesia is crucial for the correct treatment of the disease (recommendation A). Enteral feeding is indicated in severe necrotizing pancreatitis and it is better than total parenteral nutrition (recommendation A). The use of prophylactic broad-spectrum antibiotics reduces infection rates in CT-proven necrotizing pancreatitis (recommendation A). Infected pancreatic necrosis in patients with clinical signs and symptoms of sepsis is an indication for intervention, including surgery and radiological drainage (recommendation B). Conclusions: The participants agreed to revise the guidelines every 3 years in order to re-evaluate each question on the management of acute pancreatitis patients according to the most recent literature.

Keywords:
Disease management, Diagnosis, Diagnostic imaging, Pancreatic necrosis, Pancreatitis, Prognosis, Therapeutics
1.
Uomo G, Pezzilli R, Cavallini G: Management of acute pancreatitis in clinical practice. ProInf – AISP Study Group: Progetto Informatizzato Pancreatite Acuta – Associazione Italiana Studio Pancreas. Ital J Gastroenterol Hepatol 1999;31:635–642.
2.
Pezzilli R, Uomo G, Zerbi A, Gabbrielli A, Frulloni L, De Rai P, Delle Fave G, Di Carlo V, Italian Association for the Study of the Pancreas Study Group: Diagnosis and treatment of acute pancreatitis: the position statement of the Italian Association for the study of the pancreas. Dig Liver Dis 2008;40:803–808.
3.
Fervers B, Burgers JS, Haugh MC, Latreille J, Mlika-Cabanne N, Paquet L, Coulombe M, Poirier M, Burnand B: Adaptation of clinical guidelines: literature review and proposition for a framework and procedure. Int J Qual Health Care 2006;18:167–176.
4.
ADAPTE Collaboration: Resource Toolkit for Guideline Adaptation, Version 1.0, 2007 (http://www.adapte.org).
5.
The AGREE Collaboration: Appraisal of guidelines for research and evaluation. AGREE instrument, September 2001 (http://www.agreecollaboration.org).
6.
Guyatt G, Gutterman D, Baumann MH, Addrizzo-Harris D, Hylek EM, Phillips B, Raskob G, Lewis SZ, Schünemann H: Grading strength of recommendations and quality of evidence in clinical guidelines: report from an American College of Chest Physicians task force. Chest 2006;129:174–181.
7.
Brozek JL, Baena-Cagnani CE, Bonini S, Canonica GW, Rasi G, van Wijk RG, Zuberbier T, Guyatt G, Bousquet J, Schünemann HJ: Methodology for development of the allergic rhinitis and its impact on asthma guideline 2008 update. Allergy 2008;63:38–46.
8.
Bradley EL 3rd: A clinically based classification system for acute pancreatitis. Summary of the International Symposium on Acute Pancreatitis, Atlanta, Ga., September 11–13, 1992. Arch Surg 1993;128:586–590.
9.
The Society for Surgery of the Alimentary Tract Patient Care Committee: Treatment of acute pancreatitis. J Gastrointest Surg 1998;2:487–488.
10.
Dervenis C, Johnson CD, Bassi C, Bradley E, Imrie CW, McMahon MJ, Modlin I: Diagnosis, objective assessment of severity, and management of acute pancreatitis. Santorini Consensus Conference. Int J Pancreatol 1999;25:195–210.
11.
Société Nationale Française de Gastro-Entérologie: Conférence de consensus: pancréatite aiguë. Gastroenterol Clin Biol 2001;25:177–192.
12.
Uhl W, Warshaw A, Imrie C, Bassi C, McKay CJ, Lankisch PG, Carter R, Di Magno E, Banks PA, Whitcomb DC, Dervenis C, Ulrich CD, Satake K, Ghaneh P, Hartwig W, Werner J, McEntee G, Neoptolemos JP, Büchler MW, International Association of Pancreatology: IAP Guidelines for the Surgical Management of Acute Pancreatitis. Pancreatology 2002;2:565–573.
13.
Mayumi T, Ura H, Arata S, Kitamura N, Kiriyama I, Shibuya K, Sekimoto M, Nago N, Hirota M, Yoshida M, Ito Y, Hirata K, Takada T; Working Group for the Practical Guidelines for Acute Pancreatitis: Japanese Society of Emergency Abdominal Medicine: Evidence-based clinical practice guidelines for acute pancreatitis: proposals. J Hepatobiliary Pancreat Surg 2002;9:413–422.
14.
Toouli J, Brooke-Smith M, Bassi C, Carr-Locke D, Telford J, Freeny P, Imrie C, Tandon R; Working Party of the Program Commitee of the Bangkok World Congress of Gastroenterology 2002. J Gastroenterol Hepatol 2002;17(suppl):S15–S39.
15.
Working Party of the British Society of Gastroenterology; Association of Surgeons of Great Britain and Ireland; Pancreatic Society of Great Britain and Ireland; Association of Upper GI Surgeons of Great Britain and Ireland: UK guidelines for the management of acute pancreatitis. Gut 2005;54 (suppl 3):1–9.
16.
Meier R, Ockenga J, Pertkiewicz M, Pap A, Milinic N, Macfie J; DGEM (German Society for Nutritional Medicine), Löser C, Keim V; ESPEN (European Society for Parenteral and Enteral Nutrition): ESPEN Guidelines on Enteral Nutrition: pancreas. Clin Nutr 2006;25:275–284.
17.
Otsuki M, Hirota M, Arata S, Koizumi M, Kawa S, Kamisawa T, Takeda K, Mayumi T, Kitagawa M, Ito T, Inui K, Shimosegawa T, Tanaka S, Kataoka K, Saisho H, Okazaki K, Kuroda Y, Sawabu N, Takeyama Y, The Research Committee of Intractable Diseases of the Pancreas: Consensus of primary care in acute pancreatitis in Japan. World J Gastroenterol 2006;12:3314–3323.
18.
Kimura Y, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Takeda K, Isaji S, Koizumi M, Satake K, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: treatment of gallstone-induced acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:56–60.
19.
Isaji S, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Takeda K, Koizumi M, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: surgical management. J Hepatobiliary Pancreat Surg 2006;13:48–55.
20.
Takeda K, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Isaji S, Koizumi M, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: medical management of acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:42–47.
21.
Hirota M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: severity assessment of acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:33–41.
22.
Koizumi M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Takeda K, Isaji S, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: diagnostic criteria for acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:25–32.
23.
Sekimoto M, Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Hirota M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: epidemiology, etiology, natural history, and outcome predictors in acute pancreatitis. J Hepatobiliary Pancreat Surg 2006;13:10–24.
24.
Takada T, Kawarada Y, Hirata K, Mayumi T, Yoshida M, Sekimoto M, Hirota M, Kimura Y, Takeda K, Isaji S, Koizumi M, Otsuki M, Matsuno S: JPN Guidelines for the management of acute pancreatitis: cutting-edge information. J Hepatobiliary Pancreat Surg 2006;13:2–6.
25.
Ros PR, Bree RL, Foley WD, Gay SB, Glick SN, Heiken JP, Huprich JE, Levine MS, Rosen MP, Shuman WP, Greene FL, Rockey DC, Expert Panel on Gastrointestinal Imaging: Acute pancreatitis (online publication). Reston/VA, American College of Radiology, 2006.
26.
AGA Institute Medical Position Statement on Acute Pancreatitis. Gastroenterology 2007;132:2019–2021.
27.
British Society of Gastroenterology: United Kingdom guidelines for the management of acute pancreatitis. Gut 1998;42 (suppl 2):S1–S13.
28.
Stimac D, Miletić D, Radić M, Krznarić I, Mazur-Grbac M, Perković D, Milić S, Golubović V: The role of nonenhanced magnetic resonance imaging in the early assessment of acute pancreatitis. Am J Gastroenterol 2007;102:997–1004.
29.
Balthazar EJ, Freeny PC, van Sonnenberg E: Imaging and intervention in acute pancreatitis. Radiology 1994;193:297–306.
30.
Mortele KJ, Wiesner W, Intriere L, Shankar S, Zou KH, Kalantari BN, Perez A, van Sonnenberg E, Ros PR, Banks PA, Silverman SG: A modified CT severity index for evaluating acute pancreatitis: improved correlation with patient outcome. AJR Am J Roentgenol 2004;183:1261–1265.
31.
De Waele JJ, Delrue L, Hoste EA, De Vos M, Duyck P, Colardyn FA: Extrapancreatic inflammation on abdominal computed tomography as an early predictor of disease severity in acute pancreatitis: evaluation of a new scoring system. Pancreas 2007;34:185–190.
32.
Trivedi CD, Pitchumoni CS: Drug-induced pancreatitis: an update. J Clin Gastroenterol 2005;39:709–716.
33.
Tenner S, Dubner H, Steinberg W: Predicting gallstone pancreatitis with laboratory parameters: a meta-analysis. Am J Gastroenterol 1994;89:1863–1866.
34.
Lévy P, Boruchowicz A, Hastier P, Pariente A, Thévenot T, Frossard JL, Buscail L, Mauvais F, Duchmann JC, Courrier A, Bulois P, Gineston JL, Barthet M, Licht H, O’Toole D, Ruszniewski P: Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. Pancreatology 2005;5:450–456.
35.
Alexakis N, Lombard M, Raraty M, Ghaneh P, Smart HL, Gilmore I, Evans J, Hughes M, Garvey C, Sutton R, Neoptolemos JP: When is pancreatitis considered to be of biliary origin and what are the implications for management? Pancreatology 2007;7:131–141.
36.
Pezzilli R: Acute recurrent pancreatitis: an autoimmune disease? World J Gastroenterol 2008;14:999–1006.
37.
Lévy P, Boruchowicz A, Hastier P, Pariente A, Thévenot T, Frossard JL, Buscail L, Mauvais F, Duchmann JC, Courrier A, Bulois P, Gineston JL, Barthet M, Licht H, O’Toole D, Ruszniewski P: Diagnostic criteria in predicting a biliary origin of acute pancreatitis in the era of endoscopic ultrasound: multicentre prospective evaluation of 213 patients. Pancreatology 2005;5:450–456.
38.
Wilcox CM, Varadarajulu S, Eloubeidi M: Role of endoscopic evaluation in idiopathic pancreatitis: a systematic review. Gastrointest Endosc 2006;63:1037–1045.
39.
Yusoff IF, Raymond G, Sahai AV: A prospective comparison of the yield of EUS in primary vs. recurrent idiopathic acute pancreatitis. Gastrointest Endosc 2004;60:673–678.
40.
De Waele E, Op de Beeck B, De Waele B, Delvaux G: Magnetic resonance cholangiopancreatography in the preoperative assessment of patients with biliary pancreatitis. Pancreatology 2007;7:347–351.
41.
Parenti DM, Steinberg W, Kang P: Infectious causes of acute pancreatitis. Pancreas 1996;13:356–371.
42.
Whitcomb DC: Value of genetic testing in the management of pancreatitis. Gut 2004;53:1710–1717.
43.
Adler DG, Baron TH, Davila RE, Egan J, Hirota WK, Leighton JA, Qureshi W, Rajan E, Zuckerman MJ, Fanelli R, Wheeler-Harbaugh J, Faigel DO, Standards of Practice Committee of American Society for Gastrointestinal Endoscopy: ASGE guideline: the role of ERCP in diseases of the biliary tract and the pancreas. Gastrointest Endosc 2005;62:1–8.
44.
Testoni PA: Why the incidence of post-ERCP pancreatitis varies considerably? Factors affecting the diagnosis and the incidence of this complication. JOP 2002;3:195–201.
45.
Mariani A, Arcidiacono PG, Curioni S, Giussani A, Testoni PA: Diagnostic yield of ERCP and secretin-enhanced MRCP and EUS in patients with acute recurrent pancreatitis of unknown aetiology. Dig Liver Dis 2009;41:753–758.
46.
Seta T, Noguchi Y, Shimada T, Shikata S, Fukui T: Treatment of acute pancreatitis with protease inhibitors: a meta-analysis. Eur J Gastroenterol Hepatol 2004;16:1287–1293.
47.
Villatoro E, Bassi C, Larvin M: Antibiotic therapy for prophylaxis against infection of pancreatic necrosis in acute pancreatitis. Cochrane Database Syst Rev 2006;Oct 18;4:CD002941.
48.
Jafri NS, Mahid SS, Idstein SR, Hornung CA, Galandiuk S: Antibiotic prophylaxis is not protective in severe acute pancreatitis: a systematic review and meta-analysis. Am J Surg 2009;197:806–813.
49.
Pezzilli R: Antibiotic prophylaxis in severe acute pancreatitis: do we need more meta-analytic studies? JOP 2009;10:223–224.
50.
Qin RY, Qiu FZ: Imaging changes of the pancreas and the occasion of refeeding in patients with acute pancreatitis. Hepatobiliary Pancreat Dis Int 2002;1:290–293.
51.
Jacobson BC, Vander Vliet MB, Hughes MD, et al: A prospective, randomized trial of clear liquids versus low-fat solid diet as the initial meal in mild acute pancreatitis. Clin Gastroenterol Hepatol 2007;5:946–951.
52.
Sathiaraj E, Murthy S, Mansard MJ, et al: Clinical trial: oral feeding with a soft diet compared with clear liquid diet as initial meal in mild acute pancreatitis. Aliment Pharmacol Ther 2008;28:777–781.
53.
Eckerwall GE, Tingstedt BB, Bergenzaun PE, Andersson RG: Immediate oral feeding in patients with mild acute pancreatitis is safe and may accelerate recovery – a randomized clinical study. Clin Nutr 2007;26:758–763.
54.
Pezzilli R, Simoni P, Casadei R, Morselli-Labate AM: Exocrine pancreatic function during the early recovery phase of acute pancreatitis. Hepatobiliary Pancreat Dis Int 2009;8:316–319.
55.
Petrov MS, van Santvoort HC, Besselink MG, van der Heijden GJ, van Erpecum KJ, Gooszen HG: Early endoscopic retrograde cholangiopancreatography versus conservative management in acute biliary pancreatitis without cholangitis: a meta-analysis of randomized trials. Ann Surg 2008;247:250–257.
56.
Moretti A, Papi C, Aratari A, Festa V, Tanga M, Koch M, Capurso L: Is early endoscopic retrograde cholangiopancreatography useful in the management of acute biliary pancreatitis? A meta-analysis of randomized controlled trials. Dig Liver Dis 2008;40:379–385.
57.
Besselink MG, van Santvoort HC, Nieuwenhuijs VB, Boermeester MA, Bollen TL, Buskens E, Dejong CH, van Eijck CH, van Goor H, Hofker SS, Lameris JS, van Leeuwen MS, Ploeg RJ, van Ramshorst B, Schaapherder AF, Cuesta MA, Consten EC, Gouma DJ, van der Harst E, Hesselink EJ, Houdijk LP, Karsten TM, van Laarhoven CJ, Pierie JP, Rosman C, Bilgen EJ, Timmer R, van der Tweel I, de Wit RJ, Witteman BJ, Gooszen HG, Dutch Acute Pancreatitis Study Group: Minimally invasive ‘step-up approach’ versus maximal necrosectomy in patients with acute necrotising pancreatitis (PANTER trial): design and rationale of a randomised controlled multicenter trial (ISRCTN- 13975868). BMC Surg 2006;6:6.
58.
Varadarajulu S, Christein JD, Tamhane A, Drelichman ER, Wilcox CM: Prospective randomized trial comparing EUS and EGD for transmural drainage of pancreatic pseudocysts (with videos). Gastrointest Endosc 2008;68:1102–1111.
© 2010 S. Karger AG, Basel and IAP
2010
Copyright / Drug Dosage / Disclaimer
Copyright: All rights reserved. No part of this publication may be translated into other languages, reproduced or utilized in any form or by any means, electronic or mechanical, including photocopying, recording, microcopying, or by any information storage and retrieval system, without permission in writing from the publisher.
Drug Dosage: The authors and the publisher have exerted every effort to ensure that drug selection and dosage set forth in this text are in accord with current recommendations and practice at the time of publication. However, in view of ongoing research, changes in government regulations, and the constant flow of information relating to drug therapy and drug reactions, the reader is urged to check the package insert for each drug for any changes in indications and dosage and for added warnings and precautions. This is particularly important when the recommended agent is a new and/or infrequently employed drug.
Disclaimer: The statements, opinions and data contained in this publication are solely those of the individual authors and contributors and not of the publishers and the editor(s). The appearance of advertisements or/and product references in the publication is not a warranty, endorsement, or approval of the products or services advertised or of their effectiveness, quality or safety. The publisher and the editor(s) disclaim responsibility for any injury to persons or property resulting from any ideas, methods, instructions or products referred to in the content or advertisements.
You do not currently have access to this content.